Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly evolved into a global pandemic. The hyperglycemia in patients with diabetes mellitus (DM) substantially compromises their innate immune system. SARS-CoV-2 uses human angiotensin-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Yu-Huang, Zheng, Jing-Quan, Zheng, Cai-Mei, Lu, Kuo-Cheng, Chao, You-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762278/
https://www.ncbi.nlm.nih.gov/pubmed/33297431
http://dx.doi.org/10.3390/jcm9123962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762278/
https://www.ncbi.nlm.nih.gov/pubmed/33297431
http://dx.doi.org/10.3390/jcm9123962

Ejemplares similares